A host of one-offs: GAIL’s Q4 PAT (profit after tax) of R6.18 bn (-52% quarter-on-quarter) was largely impacted by a one-off provision of R5.18 bn on account of a retrospective cut in its KG basin pipeline tariff by the PNGRB (Petroleum and Natural Gas Regulatory Board). Even barring the impact of the tariff cut and despite surprisingly lower subsidy, profits were still below expectations due to bunching up of some other provisions in the quarter (R3.3 bn). FY13 standalone EPS (earnings per share) stood at R31.7/share (R28.8/sh in FY12) while consolidated energy EPS stood at R34.5/sh (R35.0/sh).
Gas volumes disappoint: Transmission volumes fell sharply q-o-q to 99 mmscmd, from 105 mmscmd in Q3, led by the continued decline in KG-D6 volumes (19 vs. 24 mmscmd), lower Dahej LNG volumes (96% vs. 110% utilisation), delay in commissioning of Kochi (now expected in July), and minimal volumes at Dabhol (meaningful contribution only from Oct).
Q1 volumes are unlikely to see a meaningful uptick as KG-D6 volumes have continued to fall, which should offset a potential pick-up at Dahej. Gas trading Ebitda of R3.49 bn was ahead sequentially (R3.0 bn in Q3) despite lower marketing volumes due to higher trading margins, while petchem Ebitda (+7% q-o-q) was also ahead of expectations. LPG segmental Ebitda was, however, down 16% q-o-q despite lower subsidy due to poorer realisations.
Subsidy surprises positively: Q4 subsidy of R5.87 bn was below the quarterly run rate of R7.0 bn and surprised positively, due to some last-minute adjustments in the final subsidy figures for the year, the benefits of which accrued to GAIL. Full-year subsidy share came in at R26.9 bn for FY13, 16% below the R31.8 bn figure for FY12. Future subsidy, however, remains a key imponderable for GAIL, especially in the likely event of an APM (administered price mechanism) gas-price hike.
Maintain Neutral: Near-term earnings growth for GAIL remains muted and positive catalysts seem elusive with APM gas prices likely to be raised and KG gas volumes continuing to decline. While valuations (10x and 1.4x adjusted P/E and P/B—price-to-earnings & price-to-book value) appear reasonable and the stock has underperformed 23% over